› 4etr

X-ray diffraction
2.25Å resolution

X-ray structure of PA2169 from Pseudomonas aeruginosa

Released:
DOI: 10.2210/pdb4etr/pdb
PDB entry 4etr coloured by chain, front view.
PDB entry 4etr coloured by chain, side view.
PDB entry 4etr coloured by chain, top view.
Source organism: Pseudomonas aeruginosa PAO1
Primary publication:
The AEROPATH project targeting Pseudomonas aeruginosa: crystallographic studies for assessment of potential targets in early-stage drug discovery.
Moynie L, Schnell R, McMahon SA, Sandalova T, Boulkerou WA, Schmidberger JW, Alphey M, Cukier C, Duthie F, Kopec J, Liu H, Jacewicz A, Hunter WN, Naismith JH, Schneider G
Acta Crystallogr Sect F Struct Biol Cryst Commun 69 25-34 (2013)
PMID: 23295481

Function and Biology Details

Biochemical function:
  • not assigned
Biological process:
  • not assigned
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-191278 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
DUF2383 domain-containing protein Chains: A, B
Molecule details ›
Chains: A, B
Length: 153 amino acids
Theoretical weight: 17.15 KDa
Source organism: Pseudomonas aeruginosa PAO1
Expression system: Escherichia coli BL21(DE3)
UniProt:
  • Canonical: Q9I1U6 (Residues: 1-150; Coverage: 100%)
Gene name: PA2169
Sequence domains: Domain of unknown function (DUF2383)
Structure domains: Ferritin

Ligands and Environments

No bound ligands
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: ESRF BEAMLINE ID23-1
Spacegroup: P21
Unit cell:
a: 40.576Å b: 71.219Å c: 48.781Å
α: 90° β: 111.62° γ: 90°
R-values:
R R work R free
0.224 0.221 0.285
Expression system: Escherichia coli BL21(DE3)

Quick links

Citations

4 review citations

Lytic transglycosylases: concinnity in concision of the bacterial cell wall.
Dik et al. (2017)
3 more

1 mention without citation

The AEROPATH project targeting Pseudomonas aeruginosa: crystallographic studies for assessment of potential targets in early-stage drug discovery.
Moynie et al. (2013)